产品: LGR5 抗体
货号: DF2816
描述: Rabbit polyclonal antibody to LGR5
应用: WB IHC IF/ICC
文献验证: WB, IF/ICC
反应: Human, Mouse
预测: Pig, Bovine, Sheep
蛋白号: O75473
RRID: AB_2840022

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IF/ICC 1:100-1:500, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse
克隆:
Polyclonal
特异性:
LGR5 Antibody detects endogenous levels of total LGR5.
RRID:
AB_2840022
引用格式: Affinity Biosciences Cat# DF2816, RRID:AB_2840022.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

FEX; G protein coupled receptor 49; G protein coupled receptor 67; g protein-coupled receptor fex; G-protein coupled receptor 49; G-protein coupled receptor 67; G-protein coupled receptor HG38; GPR 49; GPR 67; GPR49; GPR67; GRP 49; GRP49; HG 38; HG38; Leucine rich repeat containing G protein coupled receptor 5; Leucine-rich repeat-containing G-protein coupled receptor 5; LGR 5; LGR5; LGR5_HUMAN; MGC117008; Orphan G protein coupled receptor HG38;

抗原和靶标

免疫原:

A synthesized peptide derived from human LGR5, corresponding to a region within the internal amino acids.

基因/基因ID:
描述:
Orphan receptor. Stem cell marker of the intestinal epithelium and the hair follicule. Target gene of Wnt signaling.;

文献引用

1). A Nucleophilicity-Engineered DNA Ligation Blockade Nanoradiosensitizer Induces Irreversible DNA Damage to Overcome Cancer Radioresistance. Advanced materials (Deerfield Beach, Fla.), 2024 (PubMed: 39246208) [IF=27.4]

2). Molecular glue triggers degradation of PHGDH by enhancing the interaction between DDB1 and PHGDH. Acta pharmaceutica Sinica. B, 2024 (PubMed: 39309493) [IF=14.7]

Application: WB    Species: Mouse    Sample:

Figure 5. The regulatory role of PHGDH in maintaining the stemness of CRC cells. (A) Western blot analysis of PHGDH protein level in HCT-116 cells with stable expression of scrambled or PHGDH shRNA, and in parallel or PHGDH overexpression HCT-15 cells. (B) Representative micrographs of tumorspheres from HCT-116 cells bearing scrambled or PHGDH shRNA (up) or PHGDH-overexpression HCT-15 cells (down). (C) Quantification of the numbers of tumorspheres in (B). (D) Limiting dilution analysis (LDA) to assess the sphere-initiation capacity of stable PHGDH knockdown or overexpression cells. Cells were planted into 96-well plates at densities of 8, 15, 31, or 62 cells per well and cultured for 10 days, followed by counting of wells containing tumorspheres and analysis utilizing ELDA software. (E) Representative images of colony formation in soft agar. (F) Quantification of colony numbers in (E). (G) Quantitative RT-PCR analysis of CRC stem cell markers (LGR5, CD133, CD44, and CD166). (H) Detection of PHGDH protein levels of CD44 and LGR5 by Western blot. (I) Limiting dilution tumorigenesis assays conducted by subcutaneously injecting scrambled or PHGDH shRNA cells (1 × 104, 1 × 105, and 1 × 106) into BALB/c nude mice. After 39 days, animals were sacrificed. The ratio of formed tumors to the total number in each group is presented in a table and illustrated in a pie chart. (J) Images of tumors excised from mice injected with scrambled or PHGDH shRNA cells. (K) Tumor tissue weight. (L) Tumor volume growth curve for each group. (M) Western blot analysis of CD133, CD44, LGR5 and CD166 level in sh-PHGDH group and NC group. Statistical significance was determined by unpaired t-test. Error bars denoted SEM, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ∗∗∗∗P < 0.0001.

3). A bioactive calcium silicate nanowire-containing hydrogel for organoid formation and functionalization. Materials horizons, 2024 (PubMed: 38586926) [IF=12.2]

4). Bazi Bushen capsule improves the deterioration of the intestinal barrier function by inhibiting NLRP3 inflammasome-mediated pyroptosis through microbiota-gut-brain axis. Frontiers in microbiology, 2024 (PubMed: 38260869) [IF=5.2]

5). Antimicrobial agent chloroxylenol targets β‑catenin‑mediated Wnt signaling and exerts anticancer activity in colorectal cancer. International Journal of Oncology, 2023 (PubMed: 37681484) [IF=4.5]

6). Hymenolepis nana antigens alleviate ulcerative colitis by promoting intestinal stem cell proliferation and differentiation via AhR/IL-22 signaling pathway. PLoS neglected tropical diseases, 2024 (PubMed: 39666730) [IF=3.4]

7). Isoliquiritigenin alleviates radiation-induced intestinal injury in lung cancer by inhibiting TNF-α/caspase3 signaling pathway. Naunyn-Schmiedeberg's archives of pharmacology, 2025 (PubMed: 40137968) [IF=3.1]

8). Aligned membranes regulate wound healing via MMP12 secreted by macrophages. PloS one, 2025 (PubMed: 39813228) [IF=2.9]

9). Organoid culture of mouse fallopian tube epithelial stem cells with a thermo-reversible gelation polymer. TISSUE & CELL, 2021 (PubMed: 34454367) [IF=2.7]

Application: IF/ICC    Species: Mouse    Sample:

Fig. 4. Expression of the epithelial cell marker EpCAM and the stem cell marker LGR5 in the spheres. Both EpCAM (A-C) and LGR5 (D-F) were extensively expressed in the spheres. Ab (-), without application of the first antibody as a negative control (G-I). Scale bars = 25 μm.

10). Hydrogel Derived from Decellularized Porcine Small Intestinal Submucosa as a Physical Shielding Repaired the Gut Epithelial Barrier of Murine Ulcerative Colitis. Advanced Functional Materials, 2024

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.